EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The inaccuracies of gastric adenocarcinoma clinical staging and its predictive factors

Lauren M Janczewski, Dhavan Shah, Amy Wells, David J Bentrem, John D Abad, Akhil Chawla

Journal of Surgical Oncology · 2023-06 · 127 (7) · 1116-1124

DOI: 10.1002/jso.27233 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, online erschienen am 11.03.2023. Verfasst von Lauren M Janczewski und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Adenocarcinoma, Stomach Neoplasms, Esophageal Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Accurate clinical staging (CS) of gastric adenocarcinoma is important to guide treatment planning. Our objectives were to (1) assess clinical to pathologic stage migration patterns for patients with gastric adenocarcinoma, (2) identify factors associated with inaccurate CS, and (3) evaluate the association of understaging with survival.

Methods

The National Cancer Database was queried for patients who underwent upfront resection for stage I–III gastric adenocarcinoma. Multivariable logistic regression was used to detect factors associated with inaccurate understaging. Kaplan–Meier analyses and cox proportional hazards regression were performed to assess overall survival (OS) for patients with inaccurate CS.

Results

Of 14 425 analyzed patients, 5781 (40.1%) patients were inaccurately staged. Factors associated with understaging included treatment at a Comprehensive Community Cancer Program, presence of lymphovascular invasion, moderate to poor differentiation, large tumor size, and T2 disease. Based on overall CS, median OS was 51.0 months for accurately staged patients and 29.5 months for understaged patients (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenocarcinomaStomach NeoplasmsEsophageal NeoplasmsHumansNeoplasm StagingKaplan-Meier EstimateRetrospective StudiesProportional Hazards Models

Stichwörter der Autor:innen

clinical staginggastric cancerinaccurate staging

Autor:innen und Institutionen

  • Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Depatment of Surgery, Northwestern Quality Improvement, Research, & Education in Surgery (NQUIRES), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Förderung

  • NCI NIH HHS

Zitieren

APA

Janczewski, L. M., Shah, D., Wells, A., Bentrem, D. J., Abad, J. D., & Chawla, A. (2023). The inaccuracies of gastric adenocarcinoma clinical staging and its predictive factors. Journal of Surgical Oncology, 127(7), 1116-1124. https://doi.org/10.1002/jso.27233

Vancouver

Janczewski LM, Shah D, Wells A, Bentrem DJ, Abad JD, Chawla A. The inaccuracies of gastric adenocarcinoma clinical staging and its predictive factors. Journal of Surgical Oncology. 2023;127(7):1116-1124. doi:10.1002/jso.27233

BibTeX
@article{Janczewski2023,
  author = {Janczewski, Lauren M and Shah, Dhavan and Wells, Amy and Bentrem, David J and Abad, John D and Chawla, Akhil},
  title = {The inaccuracies of gastric adenocarcinoma clinical staging and its predictive factors},
  journal = {Journal of Surgical Oncology},
  year = {2023},
  volume = {127},
  number = {7},
  pages = {1116--1124},
  doi = {10.1002/jso.27233}
}
Kostenlos starten →